摘要:
The present invention provides diagnostic imaging contrast agents which exhibit improved blood retention. The novel compounds comprise: a) an image-enhancing (or signal-generating) moiety (IEM); b) a plasma protein binding moiety (PPBM); and c) a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging. These contrast agents exhibit reduced rates of both renal and hepatocellular uptake and no apparent uptake by the RE system. The agents may be targeted to the blood pool or any other biological component. Since the agent is lost less rapidly from the bloodstream, lower doses can be used at a higher margin of safety. The approach is general to both large and small molecules.
摘要:
The present invention relates to amides that have activity as SlP receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate SlP receptor activity. The compounds may be used as immunomodulators, e.g., for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non- glomerular nephrosis, hepatitis, Behcet's disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegner's granuloma; and for treating other conditions.
摘要:
Methods and contrast agents for imaging the lymph system are provided. The methods allow the diagnosis and staging of diseases of the lymph system, such as cancer and infections.
摘要:
The invention relates to novel cascade polymer complexes, to agents containing said compounds, to the use of said complexes in NMR diagnostics and to methods for producing said compounds and agents. The complex forming cascade polymer complexes according to the invention can be described by the following general formula (I): R - L - A -{ X - [ Y - ( Z - { W - Kw }z )y ]x }a-1, in which R represents an HSA binding unit, L represents a linker or a bond, A represents a cascade core of base multiplicity a containing nitrogen, X and Y independently of one another represent a direct bond or a cascade reproduction unit of reproduction multiplicity x or y, Z and W independently of one another represent a direct bond or a cascade reproduction unit of reproduction multiplicity z or w, K represents the group of a complex former, a represents the numbers 2 to 12, and x, y, z and w represent independently of one another the numbers 1 to 4, with the proviso that exactly one multiplicity of base multiplicity a of the cascade core A represents exactly one bond site to L and with the proviso that the cascade polymer complexes in the complex former groups K contain in total at least 4 ions of an element of the atomic number 20 to 29, 39, 42 to 44 or 57 to 83 and optionally comprise cations of inorganic and/or organic bases, amino acids or amino acid amides.
摘要:
The invention relates to objects which are characterised in the claims, that is, metal complexes containing perfluoroalky, comprising radicals of general formula I containing nitrogen, to a method for the production and use thereof in the NMR field and x-ray diagnosis, radiodiagnosis and radiotherapy, in addition to lymphography in the MRT field and for blood pool imaging.
摘要:
The invention relates to conjugates of metal complex hydroxypyridin derivatives and biomolecules and to the production thereof. Said conjugates are suitable for use in the form of contrast agents in NMR diagnosis. The special embodiment of ligands makes it possible to obtain a high relaxivity and to increase a NMDR maximum.
摘要:
Methods for imaging stationary targets, including thrombi, are disclosed. The methods allow the imaging of stationary targets in areas of the body subject to physiologic motion.
摘要:
The present invention relates to compounds of the general formula (I) that have activity as SIP receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate SIP receptor activity. The compounds may be used as immunomodulators, e.g., for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non-glomerular nephrosis, hepatitis, Behcet's disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegner's granuloma; and for treating other conditions.
摘要:
The present invention relates to compounds of the general formula (I) that have activity as SlP receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate SlP receptor activity. The compounds may be used as immunomodulators, e.g., for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non-glomerular nephrosis, hepatitis, Behcet's disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegner's granuloma; and for treating other conditions.